Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

NK Wolf, DU Kissiov, DH Raulet - Nature Reviews Immunology, 2023 - nature.com
Great strides have been made in recent years towards understanding the roles of natural
killer (NK) cells in immunity to tumours and viruses. NK cells are cytotoxic innate lymphoid …

Exploring the NK cell platform for cancer immunotherapy

JA Myers, JS Miller - Nature reviews Clinical oncology, 2021 - nature.com
Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system that are
capable of killing virally infected and/or cancerous cells. Nearly 20 years ago, NK cell …

NK cell-based immune checkpoint inhibition

M Khan, S Arooj, H Wang - Frontiers in immunology, 2020 - frontiersin.org
Immunotherapy, with an increasing number of therapeutic dimensions, is becoming an
important mode of treatment for cancer patients. The inhibition of immune checkpoints …

Human NK cells: surface receptors, inhibitory checkpoints, and translational applications

S Sivori, P Vacca, G Del Zotto, E Munari… - Cellular & molecular …, 2019 - nature.com
NK cells play important roles in innate defenses against viruses and in the control of tumor
growth and metastasis. The regulation/induction of NK cell function is mediated by an array …

Human NK cells, their receptors and function

L Quatrini, M Della Chiesa, S Sivori… - European journal of …, 2021 - Wiley Online Library
NK cells are cytotoxic components of innate lymphoid cells (ILC) that provide a first line of
defense against viral infections and contribute to control tumor growth and metastasis. Their …

[HTML][HTML] NK cells and ILCs in tumor immunotherapy

S Sivori, D Pende, L Quatrini, G Pietra… - Molecular aspects of …, 2021 - Elsevier
Cells of the innate immunity play an important role in tumor immunotherapy. Thus, NK cells
can control tumor growth and metastatic spread. Thanks to their strong cytolytic activity …

Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the mayo clinic phase 2 consortium (NCI …

BBY Ma, WT Lim, BC Goh, EP Hui, KW Lo… - Journal of Clinical …, 2018 - ascopubs.org
Purpose This multinational study evaluated the antitumor activity of nivolumab in
nasopharyngeal carcinoma (NPC). Tumor and plasma-based biomarkers were investigated …

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

Y Lan, D Zhang, C Xu, KW Hance, B Marelli… - Science translational …, 2018 - science.org
Antibodies targeting immune checkpoints are emerging as potent and viable cancer
therapies, but not all patients respond to these as single agents. Concurrently targeting …

Chemo-immunotherapy: a new trend in cancer treatment

C Sordo-Bahamonde, S Lorenzo-Herrero… - Cancers, 2023 - mdpi.com
Simple Summary Chemoimmunotherapy is an emerging treatment option for cancer that
combines traditional chemotherapy with immunotherapy. This approach aims to increase the …

Generation of hypoimmunogenic human pluripotent stem cells

X Han, M Wang, S Duan, PJ Franco, JHR Kenty… - Proceedings of the …, 2019 - pnas.org
Polymorphic HLAs form the primary immune barrier to cell therapy. In addition, innate
immune surveillance impacts cell engraftment, yet a strategy to control both, adaptive and …